165 related articles for article (PubMed ID: 11008203)
1. Expression of glypican 3 (GPC3) in embryonal tumors.
Saikali Z; Sinnett D
Int J Cancer; 2000 Sep; 89(5):418-22. PubMed ID: 11008203
[TBL] [Abstract][Full Text] [Related]
2. Methylation analysis of the glypican 3 gene in embryonal tumours.
Boily G; Saikali Z; Sinnett D
Br J Cancer; 2004 Apr; 90(8):1606-11. PubMed ID: 15083193
[TBL] [Abstract][Full Text] [Related]
3. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3 expression in Wilms tumor and hepatoblastoma.
Toretsky JA; Zitomersky NL; Eskenazi AE; Voigt RW; Strauch ED; Sun CC; Huber R; Meltzer SJ; Schlessinger D
J Pediatr Hematol Oncol; 2001 Nov; 23(8):496-9. PubMed ID: 11878776
[TBL] [Abstract][Full Text] [Related]
5. Somatic glypican 3 (GPC3) mutations in Wilms' tumour.
White GR; Kelsey AM; Varley JM; Birch JM
Br J Cancer; 2002 Jun; 86(12):1920-2. PubMed ID: 12085187
[TBL] [Abstract][Full Text] [Related]
6. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
Chiao E; Fisher P; Crisponi L; Deiana M; Dragatsis I; Schlessinger D; Pilia G; Efstratiadis A
Dev Biol; 2002 Mar; 243(1):185-206. PubMed ID: 11846487
[TBL] [Abstract][Full Text] [Related]
7. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
Cano-Gauci DF; Song HH; Yang H; McKerlie C; Choo B; Shi W; Pullano R; Piscione TD; Grisaru S; Soon S; Sedlackova L; Tanswell AK; Mak TW; Yeger H; Lockwood GA; Rosenblum ND; Filmus J
J Cell Biol; 1999 Jul; 146(1):255-64. PubMed ID: 10402475
[TBL] [Abstract][Full Text] [Related]
8. The Simpson-Golabi-Behmel gene, GPC3, is not involved in sporadic Wilms tumorigenesis.
Gillan TL; Hughes R; Godbout R; Grundy PE
Am J Med Genet A; 2003 Sep; 122A(1):30-6. PubMed ID: 12949968
[TBL] [Abstract][Full Text] [Related]
9. Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling.
Sung YK; Hwang SY; Farooq M; Kim JC; Kim MK
Exp Mol Med; 2003 Aug; 35(4):257-62. PubMed ID: 14508064
[TBL] [Abstract][Full Text] [Related]
10. Glypican 3 overexpression in primary and metastatic Wilms tumors.
Tretiakova M; Zynger DL; Luan C; Andeen NK; Finn LS; Kocherginsky M; Teh BT; Yang XJ
Virchows Arch; 2015 Jan; 466(1):67-76. PubMed ID: 25366870
[TBL] [Abstract][Full Text] [Related]
11. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
Lin H; Huber R; Schlessinger D; Morin PJ
Cancer Res; 1999 Feb; 59(4):807-10. PubMed ID: 10029067
[TBL] [Abstract][Full Text] [Related]
12. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.
Gonzalez AD; Kaya M; Shi W; Song H; Testa JR; Penn LZ; Filmus J
J Cell Biol; 1998 Jun; 141(6):1407-14. PubMed ID: 9628896
[TBL] [Abstract][Full Text] [Related]
13. Genotype/phenotype correlations of males affected by Simpson-Golabi-Behmel syndrome with GPC3 gene mutations: patient report and review of the literature.
Mariani S; Iughetti L; Bertorelli R; Coviello D; Pellegrini M; Forabosco A; Bernasconi S
J Pediatr Endocrinol Metab; 2003 Feb; 16(2):225-32. PubMed ID: 12713262
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.
Veugelers M; Cat BD; Muyldermans SY; Reekmans G; Delande N; Frints S; Legius E; Fryns JP; Schrander-Stumpel C; Weidle B; Magdalena N; David G
Hum Mol Genet; 2000 May; 9(9):1321-8. PubMed ID: 10814714
[TBL] [Abstract][Full Text] [Related]
15. Glypican 3 expression in pediatric malignant solid tumors.
Kinoshita Y; Tanaka S; Souzaki R; Miyoshi K; Kohashi K; Oda Y; Nakatsura T; Taguchi T
Eur J Pediatr Surg; 2015 Feb; 25(1):138-44. PubMed ID: 25344940
[TBL] [Abstract][Full Text] [Related]
16. Glypican-3 expression is silenced in human breast cancer.
Xiang YY; Ladeda V; Filmus J
Oncogene; 2001 Nov; 20(50):7408-12. PubMed ID: 11704870
[TBL] [Abstract][Full Text] [Related]
17. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
Pilia G; Hughes-Benzie RM; MacKenzie A; Baybayan P; Chen EY; Huber R; Neri G; Cao A; Forabosco A; Schlessinger D
Nat Genet; 1996 Mar; 12(3):241-7. PubMed ID: 8589713
[TBL] [Abstract][Full Text] [Related]
18. Glypican 3 and glypican 4 are juxtaposed in Xq26.1.
Huber R; Mazzarella R; Chen CN; Chen E; Ireland M; Lindsay S; Pilia G; Crisponi L
Gene; 1998 Dec; 225(1-2):9-16. PubMed ID: 9931407
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases.
Chan ES; Pawel BR; Corao DA; Venneti S; Russo P; Santi M; Sullivan LM
Pediatr Dev Pathol; 2013; 16(4):272-7. PubMed ID: 23530909
[TBL] [Abstract][Full Text] [Related]
20. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome.
Li M; Shuman C; Fei YL; Cutiongco E; Bender HA; Stevens C; Wilkins-Haug L; Day-Salvatore D; Yong SL; Geraghty MT; Squire J; Weksberg R
Am J Med Genet; 2001 Aug; 102(2):161-8. PubMed ID: 11477610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
